Infection, Human Immunodeficiency Virus I

Also known as: Human Immunodeficiency Virus I Infection / HIV-1 Infections / HIV-1 Infection / [X]Human immunodeficiency virus disease / Human immunodeficiency virus [HIV] disease / HIV disease / HIV infection NOS / Human immunodeficiency virus syndrome / Human immunodeficiency virus infection, unspecified / HIV Infections / HIV infection

DrugDrug NameDrug Description
DB01048AbacavirAbacavir (ABC) is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. Chemically, it is a synthetic carbocyclic nucleoside and is the enantiomer with 1S, 4R absolute configuration on the cyclopentene ring. In vivo, abacavir sulfate dissociates to its free base, abacavir.
DB01072AtazanavirAtazanavir (formerly known as BMS-232632) is an antiretroviral drug of the protease inhibitor (PI) class. Like other antiretrovirals, it is used to treat infection of human immunodeficiency virus (HIV). Atazanavir is distinguished from other PIs in that it can be given once-daily (rather than requiring multiple doses per day) and has lesser effects on the patient's lipid profile (the amounts of cholesterol and other fatty substances in the blood). Like other protease inhibitors, it is used only in combination with other HIV medications. The U.S. Food and Drug Administration (FDA) approved atazanavir on June 20, 2003. [Wikipedia]
DB01264DarunavirDarunavir is a protease inhibitor used to treat HIV. It acts on the HIV aspartyl protease which the virus needs to cleave the HIV polyprotein into its functional fragments.
DB00705DelavirdineA potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. [PubChem]
DB00900DidanosineA dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. [PubChem]
DB08930DolutegravirDolutegravir is indicated for HIV-1 infection for adults and children and adolescents ≥12 years of age and weighing ≥40 kg. It is marketed as Tivicay as dolutegravir sodium. 52.6 mg of dolutegravir sodium is equivalent to 50 mg dolutegravir free acid. FDA approved on August 12, 2013.
DB00625EfavirenzEfavirenz (brand names Sustiva® and Stocrin®) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1. For HIV infection that has not previously been treated, efavirenz and lamivudine in combination with zidovudine or tenofovir is the preferred NNRTI-based regimen. Efavirenz is also used in combination with other antiretroviral agents as part of an expanded postexposure prophylaxis regimen to prevent HIV transmission for those exposed to materials associated with a high risk for HIV transmission.
DB09101ElvitegravirElvitegravir is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI) used for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults. Because integrase is necessary for viral replication, inhibition prevents the integration of HIV-1 DNA into the host genome and thereby blocks the formation of the HIV-1 provirus and resulting propagation of the viral infection. Although available as a single dose tablet, elvitegravir must be used in combination with an HIV protease inhibitor coadministered with ritonavir and another antiretroviral drug. It was developed by the pharmaceutical company Gilead Sciences, which licensed EVG from Japan Tobacco in March 2008. The drug gained approval by the U.S. Food and Drug Administration on August 27, 2012 for use in adult patients starting HIV treatment for the first time as part of the fixed dose combination known as Stribild. On September 24, 2014 the FDA approved Elvitegravir (tradename Vitekta) as a single pill formulation.
DB00879EmtricitabineEmtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of HIV infection in adults. Emtricitabine is an analogue of cytidine. The drug works by inhibiting reverse transcriptase, the enzyme that copies HIV RNA into new viral DNA.
DB01319FosamprenavirFosamprenavir is a prodrug of amprenavir, an inhibitor of human immunodeficiency virus (HIV) protease.
DB00224IndinavirA potent and specific HIV protease inhibitor that appears to have good oral bioavailability. [PubChem]
DB01601LopinavirLopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is marketed by Abbott as Kaletra, a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.
DB04835MaravirocMaraviroc (brand-named Selzentry, or Celsentri outside the U.S.) is a chemokine receptor antagonist drug developed by the drug company Pfizer that is designed to act against HIV by interfering with the interaction between HIV and CCR5. It was originally labelled as UK-427857 during development but was assigned the Maraviroc name as it entered trials. It was approved for use by the FDA in August, 2007.
DB00220NelfinavirNelfinavir is a potent HIV-1 protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. Nelfinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.
DB06817RaltegravirRaltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.
DB08864RilpivirineRilpivirine is non-nucleoside reverse transcriptase inhibitor (NNRTI) which is used for the treatment of HIV-1 infections in treatment-naive patients. It is a diarylpyrimidine, a class of molecules that resemble pyrimidine nucleotides found in DNA. Because of its flexible chemical structure, resistance of rilpivirine is less likely to develop than other NNRTI's. FDA approved on May 20, 2011.
DB01232SaquinavirAn HIV protease inhibitor which acts as an analog of an HIV protease cleavage site. It is a highly specific inhibitor of HIV-1 and HIV-2 proteases. [PubChem]
DB09299Tenofovir alafenamideTenofovir alafenamide fumarate (TAF) is a nucleotide reverse transcriptase inhibitor (NRTI) and a novel ester prodrug of the antiretroviral tenofovir. Following oral administration, TAF is converted in vivo to tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5′-monophosphate. Tenofovir mimics normal DNA building blocks but is lacking a 3'-OH molecule required for phosphodiester bond linkage. By competing with regular nucleotides for incorporation into proviral DNA and prevention of the formation of the 5' to 3' phosphodiester linkage required for DNA elongation, tenofovir causes early chain termination and prevents proviral DNA transcription. Although tenofovir (available as tenofovir disoproxil fumarate) has a good safety profile and efficacy, and is currently a cornerstone of HIV antiviral treatment, its use has been associated with nephrotoxicity and reduced bone mineral density. In comparison, TAF has been shown to have improved antiviral efficacy, enhanced delivery of TFV into peripheral blood mononuclear cells (PBMCs) and lymphatic tissues, a higher barrier to resistance, and an improved safety profile. Improved renal safety is likely attributable to lower circulating plasma concentrations of tenofovir and therefore less exposure and damage to bone and the kidneys, where tenofovir is metabolized. Because HIV antiretroviral therapy is usually life-long, reduced toxicity and improved efficacy results in better patient outcomes and improved adherence in the long term. Tenofovir alafenamide fumarate is currently available in two fixed dose combination products: Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide), and Descovy (emtricitabine and tenofovir alafenamide). Both products are indicated for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older.
DB00300Tenofovir disoproxilTenofovir disoproxil fumarate (a prodrug of tenofovir), marketed by Gilead Sciences under the trade name Viread®, belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase inhibitors (nRTIs), which block reverse transcriptase, an enzyme crucial to viral production in HIV-infected people. [Wikipedia] In vivo tenofovir disoproxil fumarate is converted to tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5'-monophosphate.
DB00932TipranavirTipranavir is a sulfonamide-containing dyhydropyrone and a nonpeptidic protease inhibitor that targets the HIV protease. It is administered with ritonavir in combination therapy to treat HIV infections.
DrugDrug NameTargetType
DB01048AbacavirAlcohol dehydrogenase 6enzyme
DB01048AbacavirUDP-glucuronosyltransferase 1-1enzyme
DB01048AbacavirReverse transcriptase/RNaseHtarget
DB01048AbacavirAdenosine kinaseenzyme
DB01048AbacavirHLA class I histocompatibility antigen, B-57 alpha chaintarget
DB01072AtazanavirHuman immunodeficiency virus type 1 proteasetarget
DB01072AtazanavirCytochrome P450 3A4enzyme
DB01072AtazanavirCytochrome P450 2C9enzyme
DB01072AtazanavirMultidrug resistance protein 1transporter
DB01072AtazanavirMultidrug resistance-associated protein 1transporter
DB01072AtazanavirCytochrome P450 1A2enzyme
DB01072AtazanavirSerum albumincarrier
DB01264DarunavirHuman immunodeficiency virus type 1 proteasetarget
DB01264DarunavirCytochrome P450 3A4enzyme
DB00705DelavirdineCytochrome P450 3A4enzyme
DB00705DelavirdineCytochrome P450 2C9enzyme
DB00705DelavirdineCytochrome P450 2D6enzyme
DB00705DelavirdineCytochrome P450 3A5enzyme
DB00705DelavirdineCytochrome P450 3A7enzyme
DB00705DelavirdineCytochrome P450 2C19enzyme
DB00705DelavirdineCytochrome P450 1A2enzyme
DB00705DelavirdineCytochrome P450 2C8enzyme
DB00705DelavirdineReverse transcriptase/RNaseHtarget
DB00900DidanosineSolute carrier family 22 member 6transporter
DB00900DidanosinePurine nucleoside phosphorylasetarget
DB00900DidanosineReverse transcriptase/RNaseHtarget
DB00900DidanosineEquilibrative nucleoside transporter 1transporter
DB00900DidanosineEquilibrative nucleoside transporter 2transporter
DB00900DidanosineSerum albumincarrier
DB08930DolutegravirUDP-glucuronosyltransferase 1-1enzyme
DB08930DolutegravirPOU domain, class 2, transcription factor 2enzyme
DB08930DolutegravirCYP3Aenzyme
DB08930DolutegravirIntegrasetarget
DB00625EfavirenzCytochrome P450 2B6enzyme
DB00625EfavirenzCytochrome P450 3A4enzyme
DB00625EfavirenzCytochrome P450 2C19enzyme
DB00625EfavirenzCytochrome P450 2C9enzyme
DB00625EfavirenzCytochrome P450 1A2enzyme
DB00625EfavirenzCytochrome P450 2D6enzyme
DB00625EfavirenzReverse transcriptase/RNaseHtarget
DB00625EfavirenzCytochrome P450 2C8enzyme
DB00625EfavirenzSerum albumincarrier
DB09101ElvitegravirIntegrasetarget
DB09101ElvitegravirCytochrome P450 3A4enzyme
DB09101ElvitegravirUDP-glucuronosyltransferase 1A1enzyme
DB00879EmtricitabineReverse transcriptase/RNaseHtarget
DB00879EmtricitabineDeoxycytidine kinaseenzyme
DB00879EmtricitabineSerum albumincarrier
DB01319FosamprenavirHuman immunodeficiency virus type 1 proteasetarget
DB01319FosamprenavirCytochrome P450 3A4enzyme
DB00224IndinavirHuman immunodeficiency virus type 1 proteasetarget
DB00224IndinavirCytochrome P450 3A4enzyme
DB00224IndinavirCytochrome P450 3A5enzyme
DB00224IndinavirCytochrome P450 3A7enzyme
DB00224IndinavirMultidrug resistance protein 1transporter
DB00224IndinavirSolute carrier family 22 member 1transporter
DB00224IndinavirMultidrug resistance-associated protein 1transporter
DB00224IndinavirSolute carrier organic anion transporter family member 1A2transporter
DB00224IndinavirSolute carrier organic anion transporter family member 1B1transporter
DB00224IndinavirCanalicular multispecific organic anion transporter 1transporter
DB00224IndinavirCytochrome P450 2C19enzyme
DB00224IndinavirCytochrome P450 2C9enzyme
DB00224IndinavirCytochrome P450 2D6enzyme
DB01601LopinavirHuman immunodeficiency virus type 1 proteasetarget
DB01601LopinavirCytochrome P450 3A4enzyme
DB01601LopinavirCytochrome P450 2D6enzyme
DB01601LopinavirCytochrome P450 2C19enzyme
DB01601LopinavirMultidrug resistance protein 1transporter
DB01601LopinavirCytochrome P450 1A2enzyme
DB01601LopinavirCytochrome P450 2B6enzyme
DB01601LopinavirCytochrome P450 2C9enzyme
DB01601LopinavirCytochrome P450 2C8enzyme
DB04835MaravirocC-C chemokine receptor type 5target
DB04835MaravirocCytochrome P450 3A4enzyme
DB00220NelfinavirHIV-1 proteasetarget
DB00220NelfinavirCytochrome P450 2C19enzyme
DB00220NelfinavirCytochrome P450 3A4enzyme
DB00220NelfinavirCytochrome P450 2B6enzyme
DB00220NelfinavirCytochrome P450 3A5enzyme
DB00220NelfinavirCytochrome P450 3A7enzyme
DB00220NelfinavirMultidrug resistance protein 1transporter
DB00220NelfinavirSolute carrier family 22 member 1transporter
DB00220NelfinavirSolute carrier organic anion transporter family member 1A2transporter
DB00220NelfinavirATP-binding cassette sub-family G member 2transporter
DB00220NelfinavirSolute carrier organic anion transporter family member 1B1transporter
DB00220NelfinavirCytochrome P450 1A2enzyme
DB00220NelfinavirCytochrome P450 2C9enzyme
DB00220NelfinavirCytochrome P450 2D6enzyme
DB00220NelfinavirSerum albumincarrier
DB06817RaltegravirUDP-glucuronosyltransferase 1-1enzyme
DB06817RaltegravirIntegrasetarget
DB08864RilpivirineCytochrome P450 3A4enzyme
DB08864RilpivirineReverse transcriptase/RNaseHtarget
DB08864RilpivirineNuclear receptor subfamily 1 group I member 2target
DB08864RilpivirineCytochrome P450 2C19enzyme
DB08864RilpivirineCytochrome P450 2B6enzyme
DB08864RilpivirineCytochrome P450 1A2enzyme
DB08864RilpivirineMultidrug resistance protein 1transporter
DB08864RilpivirineATP-binding cassette sub-family G member 2transporter
DB08864RilpivirineSolute carrier organic anion transporter family member 1B1transporter
DB08864RilpivirineSolute carrier organic anion transporter family member 1B3transporter
DB01232SaquinavirHuman immunodeficiency virus type 1 proteasetarget
DB01232SaquinavirCytochrome P450 3A4enzyme
DB01232SaquinavirCytochrome P450 3A5enzyme
DB01232SaquinavirAlpha-1-acid glycoprotein 1carrier
DB01232SaquinavirSerum albumincarrier
DB01232SaquinavirCytochrome P450 3A7enzyme
DB01232SaquinavirMultidrug resistance protein 1transporter
DB01232SaquinavirSolute carrier family 22 member 1transporter
DB01232SaquinavirSolute carrier organic anion transporter family member 1A2transporter
DB01232SaquinavirATP-binding cassette sub-family G member 2transporter
DB01232SaquinavirSolute carrier organic anion transporter family member 1B1transporter
DB01232SaquinavirMultidrug resistance-associated protein 1transporter
DB01232SaquinavirCanalicular multispecific organic anion transporter 1transporter
DB01232SaquinavirCholesterol side-chain cleavage enzyme, mitochondrialenzyme
DB01232SaquinavirCytochrome P450 2C19enzyme
DB01232SaquinavirCytochrome P450 2C8enzyme
DB01232SaquinavirCytochrome P450 2C9enzyme
DB01232SaquinavirCytochrome P450 2D6enzyme
DB09299Tenofovir alafenamideReverse transcriptase/RNaseHtarget
DB00300Tenofovir disoproxilReverse transcriptase/RNaseHtarget
DB00300Tenofovir disoproxilCytochrome P450 1A2enzyme
DB00300Tenofovir disoproxilSolute carrier family 22 member 6transporter
DB00300Tenofovir disoproxilSolute carrier family 22 member 8transporter
DB00300Tenofovir disoproxilMultidrug resistance-associated protein 7transporter
DB00300Tenofovir disoproxilMultidrug resistance-associated protein 4transporter
DB00300Tenofovir disoproxilCanalicular multispecific organic anion transporter 1transporter
DB00300Tenofovir disoproxilAdenylate kinase 2, mitochondrialenzyme
DB00300Tenofovir disoproxilAdenylate kinase 4, mitochondrialenzyme
DB00300Tenofovir disoproxilNucleoside diphosphate kinase Aenzyme
DB00300Tenofovir disoproxilNucleoside diphosphate kinase Benzyme
DB00932TipranavirHuman immunodeficiency virus type 1 proteasetarget
DB00932TipranavirCytochrome P450 3A4enzyme
DB00932TipranavirCytochrome P450 2D6enzyme
DB00932TipranavirCytochrome P450 2C19enzyme
DrugDrug NamePhaseStatusCount
DB04835Maraviroc0Terminated1
DB05742AGS-0041Recruiting1
DB00041Aldesleukin1Terminated1
DB11799Bictegravir1Completed1
DB00169Cholecalciferol1Completed1
DB09065Cobicistat1Completed1
DB00115Cyanocobalamin1Completed1
DB01264Darunavir1Completed1
DB12301Doravirine1Completed2
DB06414Etravirine1Completed1
DB00927Famotidine1Completed1
DB00158Folic Acid1Completed1
DB00709Lamivudine1Completed1
DB09027Ledipasvir1Completed1
DB12999MK-61861Terminated1
DB04835Maraviroc1Completed2
DB02701Nicotinamide1Completed1
DB00338Omeprazole1Completed1
DB00082Pegvisomant1Terminated1
DB00165Pyridoxine1Completed1
DB06817Raltegravir1Completed1
DB00811Ribavirin1Completed1
DB00140Riboflavin1Completed1
DB00615Rifabutin1Completed1
DB00020Sargramostim1Terminated1
DB09325Sodium fluoride1Completed1
DB08934Sofosbuvir1Completed1
DB00152Thiamine1Completed1
DB12687Vesatolimod1Active Not Recruiting1
DB12687Vesatolimod1Recruiting1
DB00162Vitamin A1Completed1
DB00126Vitamin C1Completed1
DB00163Vitamin E1Completed1
DB02546Vorinostat1Recruiting1
DB00495Zidovudine1Completed1
DB08639Dapivirine1 / 2Completed1
DB00625Efavirenz1 / 2Completed1
DB00125L-Arginine1 / 2Completed1
DB01601Lopinavir1 / 2Completed1
DB00688Mycophenolate mofetil1 / 2Recruiting1
DB00238Nevirapine1 / 2Completed1
DB00503Ritonavir1 / 2Completed1
DB00020Sargramostim1 / 2Completed1
DB00877Sirolimus1 / 2Recruiting1
DB01015Sulfamethoxazole1 / 2Completed1
DB00440Trimethoprim1 / 2Completed1
DB02546Vorinostat1 / 2Completed1
DB01048Abacavir2Completed2
DB00945Acetylsalicylic acid2Completed3
DB01072Atazanavir2Completed3
DB01072Atazanavir2Terminated1
DB01076Atorvastatin2Completed1
DB06581Bevirimat2Completed1
DB11799Bictegravir2Active Not Recruiting1
DB04887Brecanavir2Completed1
DB01373Calcium2Completed1
DB06724Calcium Carbonate2Completed1
DB11758Cenicriviroc2Completed1
DB12074Censavudine2Terminated1
DB11121Chloroxylenol2Active Not Recruiting1
DB00169Cholecalciferol2Completed1
DB00758Clopidogrel2Completed1
DB09065Cobicistat2Completed1
DB01264Darunavir2Active Not Recruiting1
DB01264Darunavir2Completed5
DB08930Dolutegravir2Active Not Recruiting2
DB08930Dolutegravir2Completed1
DB08930Dolutegravir2Terminated1
DB12301Doravirine2Not Yet Recruiting1
DB00625Efavirenz2Completed4
DB00625Efavirenz2Terminated1
DB00879Emtricitabine2Completed8
DB06414Etravirine2Active Not Recruiting1
DB06414Etravirine2Completed1
DB01039Fenofibrate2Completed1
DB01319Fosamprenavir2Completed1
DB13119GSK-3647352Completed1
DB00982Isotretinoin2Completed1
DB00125L-Arginine2Completed1
DB00709Lamivudine2Active Not Recruiting1
DB00709Lamivudine2Completed4
DB00709Lamivudine2Not Yet Recruiting1
DB00709Lamivudine2Terminated3
DB09027Ledipasvir2Completed1
DB01601Lopinavir2Terminated1
DB04835Maraviroc2Completed2
DB00603Medroxyprogesterone acetate2Completed1
DB00627Niacin2Completed1
DB11768O-(2,4-dichlorophenyl)-O-methyl-isopropylphosphoramidothioate2Completed2
DB00022Peginterferon alfa-2b2Active Not Recruiting1
DB00175Pravastatin2Withdrawn1
DB00396Progesterone2Not Yet Recruiting1
DB06817Raltegravir2Active Not Recruiting1
DB06817Raltegravir2Completed1
DB00811Ribavirin2Completed2
DB01220Rifaximin2Completed1
DB08864Rilpivirine2Completed1
DB00503Ritonavir2Active Not Recruiting1
DB00503Ritonavir2Completed10
DB00503Ritonavir2Recruiting1
DB00503Ritonavir2Terminated2
DB01098Rosuvastatin2Unknown Status1
DB00658Sevelamer2Completed1
DB01261Sitagliptin2Completed1
DB08934Sofosbuvir2Completed1
DB00966Telmisartan2Completed1
DB09299Tenofovir alafenamide2Active Not Recruiting1
DB00300Tenofovir disoproxil2Completed6
DB00300Tenofovir disoproxil2Terminated1
DB00495Zidovudine2Completed2
DB00495Zidovudine2Terminated1
DB11799Bictegravir2 / 3Active Not Recruiting1
DB09299Tenofovir alafenamide2 / 3Active Not Recruiting1
DB01048Abacavir3Active Not Recruiting3
DB01048Abacavir3Completed5
DB01072Atazanavir3Active Not Recruiting2
DB01072Atazanavir3Completed1
DB11799Bictegravir3Active Not Recruiting3
DB00290Bleomycin3Recruiting1
DB11588Carbon monoxide3Active Not Recruiting1
DB09065Cobicistat3Active Not Recruiting5
DB09065Cobicistat3Completed1
DB09065Cobicistat3Not Yet Recruiting1
DB09065Cobicistat3Recruiting1
DB01264Darunavir3Active Not Recruiting2
DB01264Darunavir3Completed3
DB01264Darunavir3Not Yet Recruiting1
DB01264Darunavir3Terminated1
DB08930Dolutegravir3Active Not Recruiting2
DB08930Dolutegravir3Completed2
DB08930Dolutegravir3Not Yet Recruiting1
DB08930Dolutegravir3Recruiting2
DB08930Dolutegravir3Unknown Status1
DB00476Duloxetine3Completed1
DB00625Efavirenz3Active Not Recruiting2
DB00625Efavirenz3Completed3
DB00625Efavirenz3Recruiting3
DB09101Elvitegravir3Active Not Recruiting4
DB09101Elvitegravir3Completed1
DB09101Elvitegravir3Recruiting1
DB00879Emtricitabine3Active Not Recruiting10
DB00879Emtricitabine3Completed7
DB00879Emtricitabine3Not Yet Recruiting1
DB00879Emtricitabine3Recruiting2
DB00773Etoposide3Active Not Recruiting1
DB00773Etoposide3Recruiting1
DB06414Etravirine3Completed1
DB01319Fosamprenavir3Completed2
DB00406Gentian Violet3Completed1
DB00125L-Arginine3Completed3
DB00174L-Asparagine3Completed1
DB00117L-Histidine3Completed1
DB00120L-Phenylalanine3Active Not Recruiting6
DB00120L-Phenylalanine3Completed1
DB00120L-Phenylalanine3Recruiting1
DB00709Lamivudine3Active Not Recruiting6
DB00709Lamivudine3Completed5
DB00709Lamivudine3Recruiting1
DB09027Ledipasvir3Completed1
DB01601Lopinavir3Completed2
DB04835Maraviroc3Completed2
DB00646Nystatin3Completed1
DB01229Paclitaxel3Recruiting1
DB00806Pentoxifylline3Recruiting1
DB00230Pregabalin3Terminated1
DB06817Raltegravir3Completed4
DB06817Raltegravir3Recruiting1
DB06817Raltegravir3Terminated1
DB06817Raltegravir3Unknown Status1
DB05083Rilpivirine3Active Not Recruiting1
DB08864Rilpivirine3Active Not Recruiting3
DB08864Rilpivirine3Completed4
DB00503Ritonavir3Active Not Recruiting2
DB00503Ritonavir3Completed3
DB00503Ritonavir3Terminated1
DB08934Sofosbuvir3Completed1
DB09299Tenofovir alafenamide3Active Not Recruiting12
DB09299Tenofovir alafenamide3Completed1
DB09299Tenofovir alafenamide3Recruiting2
DB00300Tenofovir disoproxil3Active Not Recruiting7
DB00300Tenofovir disoproxil3Completed8
DB00300Tenofovir disoproxil3Not Yet Recruiting1
DB00300Tenofovir disoproxil3Recruiting2
DB00541Vincristine3Recruiting1
DB00495Zidovudine3Completed1
DB01048Abacavir4Completed3
DB01072Atazanavir4Completed2
DB01072Atazanavir4Unknown Status1
DB09065Cobicistat4Completed1
DB09065Cobicistat4Recruiting1
DB01264Darunavir4Active Not Recruiting2
DB01264Darunavir4Recruiting1
DB01264Darunavir4Unknown Status1
DB00705Delavirdine4Completed1
DB08930Dolutegravir4Active Not Recruiting1
DB08930Dolutegravir4Recruiting1
DB00625Efavirenz4Active Not Recruiting1
DB00625Efavirenz4Completed4
DB09101Elvitegravir4Completed1
DB00879Emtricitabine4Active Not Recruiting3
DB00879Emtricitabine4Completed5
DB00330Ethambutol4Active Not Recruiting1
DB06414Etravirine4Active Not Recruiting1
DB06414Etravirine4Completed1
DB10300Human papillomavirus type 11 L1 capsid protein antigen4Active Not Recruiting1
DB01362Iohexol4Completed1
DB00951Isoniazid4Active Not Recruiting1
DB00125L-Arginine4Unknown Status1
DB00709Lamivudine4Active Not Recruiting3
DB00709Lamivudine4Completed4
DB00678Losartan4Completed1
DB04835Maraviroc4Unknown Status1
DB00238Nevirapine4Completed1
DB00339Pyrazinamide4Active Not Recruiting1
DB06817Raltegravir4Active Not Recruiting1
DB06817Raltegravir4Completed3
DB01045Rifampicin4Active Not Recruiting1
DB08864Rilpivirine4Completed1
DB00503Ritonavir4Active Not Recruiting1
DB00503Ritonavir4Completed1
DB12434Steviolbioside4Completed1
DB00300Tenofovir disoproxil4Active Not Recruiting3
DB00300Tenofovir disoproxil4Completed5
DB00495Zidovudine4Active Not Recruiting1
DB00495Zidovudine4Completed2
DB01048AbacavirNot AvailableCompleted2
DB00518AlbendazoleNot AvailableUnknown Status1
DB01072AtazanavirNot AvailableCompleted1
DB01264DarunavirNot AvailableCompleted1
DB00822DisulfiramNot AvailableCompleted1
DB00879EmtricitabineNot AvailableCompleted1
DB00879EmtricitabineNot AvailableNot Yet Recruiting1
DB01319FosamprenavirNot AvailableCompleted1
DB00709LamivudineNot AvailableCompleted2
DB01601LopinavirNot AvailableCompleted3
DB04835MaravirocNot AvailableCompleted1
DB08860PitavastatinNot AvailableRecruiting1
DB01058PraziquantelNot AvailableUnknown Status1
DB06817RaltegravirNot AvailableCompleted1
DB00503RitonavirNot AvailableCompleted3
DB00300Tenofovir disoproxilNot AvailableCompleted1
DB00300Tenofovir disoproxilNot AvailableNot Yet Recruiting1
DB00495ZidovudineNot AvailableCompleted1